Latest Insider Transactions at Corcept Therapeutics Inc (CORT)
This section provides a real-time view of insider transactions for Corcept Therapeutics Inc (CORT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CORCEPT THERAPEUTICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CORCEPT THERAPEUTICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 10
2025
|
Daniel N Swisher Jr |
SELL
Open market or private sale
|
Direct |
2,200
-100.0%
|
$110,000
$50.54 P/Share
|
|
Jan 10
2025
|
Daniel N Swisher Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+50.0%
|
$26,400
$12.13 P/Share
|
|
Jan 03
2025
|
Gary Charles Robb Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,037
+11.59%
|
$9,111
$3.29 P/Share
|
|
Jan 02
2025
|
Sean Maduck |
SELL
Open market or private sale
|
Direct |
20,000
-18.99%
|
$1,000,000
$50.39 P/Share
|
|
Jan 02
2025
|
Sean Maduck |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+15.96%
|
$60,000
$3.88 P/Share
|
|
Jan 02
2025
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
5,000
-36.34%
|
$250,000
$50.39 P/Share
|
|
Jan 02
2025
|
Joseph Douglas Lyon |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+26.65%
|
$55,000
$11.35 P/Share
|
|
Jan 02
2025
|
Gary Charles Robb Chief Business Officer |
SELL
Open market or private sale
|
Direct |
11,000
-35.35%
|
$550,000
$50.5 P/Share
|
|
Jan 02
2025
|
Gary Charles Robb Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+26.12%
|
$33,000
$3.29 P/Share
|
|
Jan 01
2025
|
G Leonard Baker Jr Director |
SELL
Bona fide gift
|
Indirect |
0
|
-
|
|
Dec 27
2024
|
James N Wilson |
SELL
Bona fide gift
|
Indirect |
7,800
-0.59%
|
-
|
|
Dec 10
2024
|
Daniel N Swisher Jr |
SELL
Open market or private sale
|
Direct |
2,200
-100.0%
|
$129,800
$59.46 P/Share
|
|
Dec 10
2024
|
Daniel N Swisher Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+50.0%
|
$26,400
$12.13 P/Share
|
|
Dec 02
2024
|
William Guyer Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
309
-5.33%
|
$17,613
$57.68 P/Share
|
|
Dec 02
2024
|
Sean Maduck |
BUY
Grant, award, or other acquisition
|
Direct |
530
+0.31%
|
$15,370
$29.61 P/Share
|
|
Dec 02
2024
|
Sean Maduck |
SELL
Payment of exercise price or tax liability
|
Direct |
295
-0.35%
|
$16,815
$57.68 P/Share
|
|
Dec 02
2024
|
Joseph Douglas Lyon |
BUY
Grant, award, or other acquisition
|
Direct |
430
+2.43%
|
$12,470
$29.61 P/Share
|
|
Dec 02
2024
|
Joseph Douglas Lyon |
SELL
Payment of exercise price or tax liability
|
Direct |
165
-1.94%
|
$9,405
$57.68 P/Share
|
|
Dec 02
2024
|
Gary Charles Robb Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
580
+1.43%
|
$16,820
$29.61 P/Share
|
|
Dec 02
2024
|
Gary Charles Robb Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
324
-1.63%
|
$18,468
$57.68 P/Share
|
|
Dec 02
2024
|
Atabak Mokari Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
462
+1.79%
|
$13,398
$29.61 P/Share
|
|
Dec 02
2024
|
Atabak Mokari Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
182
-1.45%
|
$10,374
$57.68 P/Share
|
|
Nov 22
2024
|
Gary Charles Robb Chief Business Officer |
SELL
Bona fide gift
|
Direct |
300
-1.49%
|
-
|
|
Nov 22
2024
|
Gary Charles Robb Chief Business Officer |
SELL
Open market or private sale
|
Direct |
2,609
-11.46%
|
$146,104
$56.2 P/Share
|
|
Nov 22
2024
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct |
1,411
-14.25%
|
$79,016
$56.72 P/Share
|
|
Nov 11
2024
|
Daniel N Swisher Jr |
SELL
Open market or private sale
|
Direct |
2,200
-100.0%
|
$129,800
$59.88 P/Share
|
|
Nov 11
2024
|
Daniel N Swisher Jr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+50.0%
|
$26,400
$12.13 P/Share
|
|
Nov 04
2024
|
William Guyer Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,394
-36.93%
|
$162,912
$48.97 P/Share
|
|
Nov 04
2024
|
William Guyer Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,394
+26.97%
|
$71,274
$21.65 P/Share
|
|
Nov 01
2024
|
William Guyer Chief Development Officer |
SELL
Open market or private sale
|
Direct |
6,606
-53.27%
|
$317,088
$48.97 P/Share
|
|
Nov 01
2024
|
William Guyer Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,606
+34.75%
|
$138,726
$21.65 P/Share
|
|
Oct 01
2024
|
William Guyer Chief Development Officer |
SELL
Open market or private sale
|
Direct |
10,000
-63.31%
|
$460,000
$46.28 P/Share
|
|
Oct 01
2024
|
William Guyer Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+38.77%
|
$210,000
$21.65 P/Share
|
|
Oct 01
2024
|
Gary Charles Robb Chief Business Officer |
SELL
Open market or private sale
|
Direct |
11,000
-32.57%
|
$506,000
$46.28 P/Share
|
|
Oct 01
2024
|
Gary Charles Robb Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+24.57%
|
$33,000
$3.29 P/Share
|
|
Sep 27
2024
|
Gary Charles Robb Chief Business Officer |
BUY
Bona fide gift
|
Indirect |
830
+4.12%
|
-
|
|
Sep 18
2024
|
Gary Charles Robb Chief Business Officer |
SELL
Other acquisition or disposition
|
Indirect |
7,250
-100.0%
|
-
|
|
Sep 18
2024
|
Gary Charles Robb Chief Business Officer |
SELL
Bona fide gift
|
Direct |
870
-3.68%
|
-
|
|
Sep 17
2024
|
Gary Charles Robb Chief Business Officer |
SELL
Bona fide gift
|
Direct |
300
-1.25%
|
-
|
|
Sep 03
2024
|
Joseph Douglas Lyon |
BUY
Grant, award, or other acquisition
|
Direct |
744
+3.69%
|
$12,648
$17.13 P/Share
|
|
Sep 03
2024
|
Joseph Douglas Lyon |
SELL
Payment of exercise price or tax liability
|
Direct |
129
-1.39%
|
$4,515
$35.3 P/Share
|
|
Sep 03
2024
|
Atabak Mokari Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
800
+3.15%
|
$13,600
$17.13 P/Share
|
|
Sep 03
2024
|
Atabak Mokari Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
143
-1.21%
|
$5,005
$35.3 P/Share
|
|
Sep 03
2024
|
Sean Maduck |
BUY
Grant, award, or other acquisition
|
Direct |
916
+0.54%
|
$15,572
$17.13 P/Share
|
|
Sep 03
2024
|
Sean Maduck |
SELL
Payment of exercise price or tax liability
|
Direct |
232
-0.27%
|
$8,120
$35.3 P/Share
|
|
Sep 03
2024
|
William Guyer Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
243
-4.02%
|
$8,505
$35.3 P/Share
|
|
Sep 03
2024
|
William Guyer Chief Development Officer |
SELL
Open market or private sale
|
Direct |
10,000
-62.35%
|
$350,000
$35.3 P/Share
|
|
Sep 03
2024
|
William Guyer Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+38.4%
|
$210,000
$21.65 P/Share
|
|
Sep 03
2024
|
Gary Charles Robb Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,006
+2.08%
|
$17,102
$17.13 P/Share
|
|
Sep 03
2024
|
Gary Charles Robb Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
254
-1.1%
|
$8,890
$35.3 P/Share
|